[theflyonthewall.com] – BMO Capital believes that the results of trials of Pfizer’s CAPITA and PALOMA-1 drugs are very likely to be positive. The firm recommends buying the stock ahead of clinical results of trials of the drugs. …
Read more on this.
Pfizer Inc. (PFE), … [visit site to read more]
Similar Articles:- Medtronic Inc. (NYSE:MDT) | Medtronic hypertension device found ineffective in trial
- Company Update – AbbVie Inc. (NYSE:ABBV) – European drug trial secrecy case hit by delay
- More impetus for a summer stock market correction